Abstract
Cytotoxic chemotherapies and immunotherapies cause harmful side effects in over half of patients with cancer. Early intervention is critical for improving outcomes, but in outpatient settings, patient self-assessment and patient-initiated pursuit of follow-up care often cause delays. Digital health technologies for remote patient monitoring (RPM) can minimize these delays. This study assessed the feasibility and perceived user experience of RPM technology for early detection of febrile neutropenia and infection in allogeneic bone marrow transplant (BMT) patients. Ten BMT patients between the ages of 18 and 89 years wore biometric monitoring devices for up to 90 days post-transplant. Devices sent real-time alerts to clinicians in response to elevated temperature, heart rate, or respiratory rate. Patients and caregivers completed surveys about their experience at 30 and 90 days post-transplant; patients were asked to participate in interviews at these time points. Providers completed surveys at the end of the study. Biometric and health utilization outcomes and responses to survey items were analyzed through descriptive statistics. Rapid content analysis of survey data and interview data was conducted to explore emergent themes. Seven patients wore RPM devices until study completion. 369 alerts were generated, with 101 requiring follow-up. Two patients had infections during the study. One had infection detected through alert data and received outpatient treatment; the second stopped wearing their device prior to symptom onset and required hospitalization. Overall, RPM technology was perceived as generally acceptable, comfortable, and easy to use. Refinements to alerting practices and technology performance are recommended to improve adoption and use as intended in the outpatient setting.
References
Alvarez, P., Sianis, A., Brown, J., Ali, A., & Briasoulis, A. (2021). Chronic disease management in heart failure: Focus on telemedicine and remote monitoring. Reviews in Cardiovascular Medicine, 22(2), 403–413. https://doi.org/10.31083/j.rcm2202046
Baus, C. J., Kelley, B., Dow-Hillgartner, E., Kyriakopoulos, C. E., Schulz, L. T., Lepak, A. J., & LoConte, N. K. (2023). Neutropenic fever-associated admissions among patients with solid tumors receiving chemotherapy during the COVID-19 pandemic. JAMA Network Open, 6(3), e234881. https://doi.org/10.1001/jamanetworkopen.2023.4881
Bolam, S. M., Batinica, B., Yeung, T. C., Weaver, S., Cantamessa, A., Vanderboor, T. C., Yeung, S., Munro, J. T., Fernandez, J. W., Besier, T. F., & Monk, A. P. (2021). Remote patient monitoring with wearable sensors following knee arthroplasty. Sensors, 21(15), Article 5143. https://doi.org/10.3390/s21155143
Carmona-Bayonas, A., & Jimenez-Fonseca, P. (2018). CISNE or MASCC, which predictor is really the weakest in febrile neutropenia? European Journal of Internal Medicine, 50, e33–e34. https://doi.org/10.1016/j.ejim.2017.11.009
Casanovas-Blanco, M., & Serrahima-Mackay, A. (2020). Febrile neutropenia management in cancer patients receiving anti-cancer agents’ treatment: Deepening the search to offer the best care. A critical review follow-up. Critical Reviews in Oncology/Hematology, 153, 103042. https://doi.org/10.1016/j.critrevonc.2020.103042
Celebi, H., Akan, H., Akçağlayan, E., Ustün, C., & Arat, M. (2000). Febrile neutropenia in allogeneic and autologous peripheral blood stem cell transplantation and conventional chemotherapy for malignancies. Bone Marrow Transplantation, 26(2), 211–214. https://doi.org/10.1038/sj.bmt.1702503
Clarke, R. T., Warnick, J., Stretton, K., & Littlewood, T. J. (2011). Improving the immediate management of neutropenic sepsis in the UK: Lessons from a national audit. British Journal of Haematology, 153(6), 773–779. https://doi.org/10.1111/j.1365-2141.2011.08693.x
De Bock, R., & Middelheim, A. Z. (2000). Febrile neutropenia in allogeneic transplantation. International Journal of Antimicrobial Agents, 16(2), 177–180. https://doi.org/10.1016/S0924-8579(00)00236-3
De Castro Carpeño, J., Gascón-Vilaplana, P., Tejerina, A. M., Antón-Torres, A., López-López, R., Barnadas-Molins, A., Cruz-Hernández, J. J., Massuti-Sureda, B., Camps-Herrero, C., Aranda-Aguilar, E., & Laserna, F. J. (2015). Epidemiology and characteristics of febrile neutropenia in oncology patients from Spanish tertiary care hospitals: PINNACLE study. Molecular and Clinical Oncology, 3(3), 725–729. https://doi.org/10.3892/mco.2015.524
Flowers, C. R., Seidenfeld, J., Bow, E. J., Karten, C., Gleason, C., Hawley, D. K., Kuderer, N. M., Langston, A. A., Marr, K. A., Rolston, K. V., & Ramsey, S. D. (2013). Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline. Journal of Clinical Oncology, 31(6), 794–810. https://doi.org/10.1200/JCO.2012.45.8661
Freifeld, A. G., Bow, E. J., Sepkowitz, K. A., Boeckh, M. J., Ito, J. I., Mullen, C. A., Raad, I. I., Rolston, K. V., Young, J. A., & Wingard, J. R. (2011). Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clinical Infectious Diseases, 52(4), e56–e93. https://doi.org/10.1093/cid/cir073
Gaieski, D. F., Mikkelsen, M. E., Band, R. A., Pines, J. M., Massone, R., Furia, F. F., Shofer, F. S., & Goyal, M. (2010). Impact of time to antibiotics on survival in patients with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the emergency department. Critical Care Medicine, 38(4), 1045–1053. https://doi.org/10.1097/CCM.0b013e3181cc4824
Harris, P., Taylor, R., Minor, B., Elliott, V., Fernandez, M., O’Neal, L., McLeod, L., Delacqua, G., Delacqua, F., Kirby, J., Duda, S., & REDCap Consortium. (2019). The REDCap consortium: Building an international community of software platform partners. Journal of Biomedical Informatics, 95, 103208. https://doi.org/10.1016/j.jbi.2019.103208
Harris, P., Taylor, R., Thielke, R., Payne, J., Gonzalez, N., & Conde, J. (2009). Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics support. Journal of Biomedical Informatics, 42(2), 377–381. https://doi.org/10.1016/j.jbi.2008.08.010
Hasan Shandhi, M. M., Aras, M., Wynn, S., Fan, J., Heller, J. A., Etemadi, M., Klein, L., & Inan, O. T. (2020). Cardiac function monitoring for patients undergoing cancer treatments using wearable seismocardiography: A proof-of-concept study. Annual International Conference of the IEEE Engineering in Medicine and Biology Society, 2020, 4075–4078. https://doi.org/10.1109/EMBC44109.2020.9176074
Itelman, E., Shlomai, G., Leibowitz, A., Weinstein, S., Yakir, M., Tamir, I., Sagiv, M., Muhsen, A., Perelman, M., Kant, D., Zilber, E., & Segal, G. (2022). Assessing the usability of a novel wearable remote patient monitoring device for the early detection of in-hospital patient deterioration: Observational study. JMIR Formative Research, 6(6), e36066. https://doi.org/10.2196/36066
Jacobsen, M., Rottmann, P., Dembek, T. A., Gerke, A. L., Gholamipoor, R., Blum, C., Hartmann, N. U., Verket, M., Kaivers, J., Jager, P., Baermann, B. N., Heinemann, L., Marx, N., Müller-Wieland, D., Kollmann, M., Seyfarth, M., & Kobbe, G. (2022). Feasibility of wearable-based remote monitoring in patients during intensive treatment for aggressive hematologic malignancies. JCO Clinical Cancer Informatics, 6, e2100126. https://doi.org/10.1200/CCI.21.00126
Klastersky, J., Raftopoulos, H., & Rapoport, B. (2013). The MASCC Neutropenia, Infection and Myelosuppression Study Group evaluates recent new concepts for the use of granulocyte colony-stimulating factors for the prevention of febrile neutropenia. Supportive Care in Cancer, 21(6), 1793–1795. https://doi.org/10.1007/s00520-013-1776-9
Lyman, G. H., Abella, E., & Pettengell, R. (2014). Risk factors for febrile neutropenia among patients with cancer receiving chemotherapy: A systematic review. Critical Reviews in Oncology/Hematology, 90(3), 190–199. https://doi.org/10.1016/j.critrevonc.2013.12.006
Mehta, S. J., Hume, E., Troxel, A. B., Reitz, C., Norton, L., Lacko, H., McDonald, C., Freeman, J., Marcus, N., Volpp, K. G., & Asch, D. A. (2020). Effect of remote monitoring on discharge to home, return to activity, and rehospitalization after hip and knee arthroplasty: A randomized clinical trial. JAMA Network Open, 3(12), e2028328. https://doi.org/10.1001/jamanetworkopen.2020.28328
Nesher, L., & Rolston, K. V. I. (2019). Febrile neutropenia in transplant recipients. In A. Safdar (Ed.), Principles and practice of transplant infectious diseases (pp. 185–198). Springer. https://doi.org/10.1007/978-1-4939-9034-4_9
Rosa, R. G., & Goldani, L. Z. (2014). Cohort study of the impact of time to antibiotic administration on mortality in patients with febrile neutropenia. Antimicrobial Agents and Chemotherapy, 58(7), 3799–3803. https://doi.org/10.1128/AAC.02561-14
Sahin, U., Toprak, S. K., Atilla, P. A., Atilla, E., & Demirer, T. (2016). An overview of infectious complications after allogeneic hematopoietic stem cell transplantation. Journal of Infection and Chemotherapy, 22(8), 505–514. https://doi.org/10.1016/j.jiac.2016.05.006
Schroeder, T., Stelljes, M., Christopeit, M., Esseling, E., Scheid, C., Mikesch, J. H., Rautenberg, C., Jäger, P., Cadeddu, R. P., Drusenheimer, N., Holtick, U., Klein, S., Trenschel, R., Haas, R., Germing, U., Kröger, N., & Kobbe, G. (2023). Azacitidine, lenalidomide and donor lymphocyte infusions for relapse of myelodysplastic syndrome, acute myeloid leukemia and chronic myelomonocytic leukemia after allogeneic transplant: The Azalena-Trial. Haematologica, 108(11), 3001–3010. https://doi.org/10.3324/haematol.2022.282570
Taplitz, R. A., Kennedy, E. B., Bow, E. J., Crews, J., Gleason, C., Hawley, D. K., Langston, A. A., Nastoupil, L. J., Rajotte, M., Rolston, K., Strasfeld, L., & Flowers, C. R. (2018b). Outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America clinical practice guideline update. Journal of Clinical Oncology, 36(14), 1443–1453. https://doi.org/10.1200/JCO.2017.77.6211
Taplitz, R. A., Kennedy, E. B., & Flowers, C. R. (2018a). Outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America clinical practice guideline update summary. Journal of Oncology Practice, 14(4), 250–255. https://doi.org/10.1200/JOP.18.00016
Taylor, J. (2018). Calculated decisions: MASCC risk index for febrile neutropenia. Emergency Medicine Practice, 20(Suppl 1), 3–4.
van der Stam, J. A., Mestrom, E. H. J., Nienhuijs, S. W., de Hingh, I., Boer, A. K., van Riel, N. A. W., de Groot, K. T. J., Verhaegh, W., Scharnhorst, V., & Bouwman, R. A. (2023). A wearable patch-based remote early warning score (REWS) in major abdominal cancer surgery patients. European Journal of Surgical Oncology, 49(1), 278–284. https://doi.org/10.1016/j.ejso.2022.08.034
Winston, D. J., Gale, R. P., Meyer, D. V., & Young, L. S. (1979). Infectious complications of human bone marrow transplantation. Medicine, 58(1), 1–31. https://doi.org/10.1097/00005792-197901000-00001
Zheng, B., Toarta, C., Cheng, W., Taljaard, M., Reaume, N., & Perry, J. J. (2020). Accuracy of the Multinational Association of Supportive Care in Cancer (MASCC) and Clinical Index of Stable Febrile Neutropenia (CISNE) scores for predicting serious complications in adult patients with febrile neutropenia: A systematic review and meta-analysis. Critical Reviews in Oncology/Hematology, 149, 102922. https://doi.org/10.1016/j.critrevonc.2020.102922
